SARS-CoV-2 and Cancer: Beyond Immunosuppression

Acta Med Port. 2021 Mar 1;34(3):237. doi: 10.20344/amp.15640. Epub 2021 Jan 22.
No abstract available

Keywords: COVID-19; Immunosuppression; Neoplasms; SARS-CoV-2.

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • COVID-19 / immunology*
  • COVID-19 / mortality
  • COVID-19 Drug Treatment
  • Coinfection / mortality
  • Dexamethasone / therapeutic use
  • Humans
  • Immune Tolerance
  • Immunocompromised Host / immunology*
  • Immunosuppressive Agents / therapeutic use
  • Interferon-gamma / metabolism
  • Interleukins / metabolism
  • Neoplasms / immunology*
  • Neoplasms / mortality
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Interleukins
  • Tumor Necrosis Factor-alpha
  • Dexamethasone
  • Interferon-gamma